Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa
NCT00381472
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
393
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Ropinirole
Sponsor
GlaxoSmithKline